Description
Larfen Raloxifene
- Name: Larfen
- Maker: Pharmathen (Greece)
- Substance: 28 x 60mg raloxifene tablets
- Half-life: 24 hours
- Other names: Evista, EviMed, Optruma and Raloxos.
Benefits
Raloxifene is a selective estrogen receptor modulator (SERM) that has anti-estrogenic effects in certain tissues, including the breast.
By blocking the effects of estrogen in the breast tissue, Larfen 60mg by Mega Lifesciences may help reduce the breast enlargement seen in gynecomastia.
It has been used off-label for this purpose, as raloxifene is not specifically approved for treating gyno.
Studies have shown Larfen can be effective in reducing breast size and improving symptoms in some cases of gynecomastia.
It may work best for patients with recent-onset gyno or those with an underlying hormonal imbalance contributing to the condition.
Other treatment options for gynecomastia include medications like tamoxifen, surgery to remove excess tissue, and addressing any underlying hormonal causes.
